Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
294.48 USD | +0.32% |
|
+2.84% | +12.62% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration